Drug Detail

Information about Durvalumab + Trememimumab

Generic Name
Durvalumab + Trememimumab
IND
Brand Name (US)
Manufacturer
Drug Type
Delivery
Intravenous
Approval Status
Indications
Overall Strategy
Immune system
Strategy
Immune checkpoint inhibitor
Drug Category
PD-L1 + CTLA-4 inhibitor